retatrutide triple agonist weight loss trial Eli Lilly's Phase 3 clinical studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial loss. Read about the work via the link in the comments 🚨Breaking: Retatrutide's first Phase 3

In cardiovascular research, fluid retention and metabolic changes linked to these peptides may complicate studies involving heart failure or severe hypertension

L., Masri, R., Pulimood, N

The extent of increases in diuretic and natriuretic, as well as CrCl responses to GLP-1 by T-RDN was greater in HF than Sham

P., & Nagaraju, K

Monitoring Progress When addressing elevated GGT, it is helpful to track: GGT trends over time AST and ALT Fasting glucose and insulin Lipid markers Inflammatory markers Improvement in GGT often precedes visible changes elsewhere

| Types and locations of cramps | Managing muscle cramps | When to seek medical help | Comparison with other medications | Frequently asked questions | Take home message Mounjaro (tirzepatide) can cause muscle cramps in some people